The RAGE antagonism with azeliragon prevents MASLD and hepatic insulin resistance by modulating glycolipid metabolism and dicarbonyl stress in diet-induced dysmetabolic mice

azeliragon (TTP488) - Cantex Pharma

R. Mastrocola 1; G. Corsini 1; E. Porchietto 2; M. van de Waarenburg 3; P.I. Rivas Navarrete 2; J.L.J. Scheijen 3; C. Schalkwijk 3; M. Collino 2

Jul 1, 2026